Entero Healthcare Solutions Ltd
NSE:ENTERO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
949.2
1 549.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of ENTERO.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Entero Healthcare Solutions Ltd
Balance Sheet Decomposition
Entero Healthcare Solutions Ltd
| Current Assets | 20.8B |
| Cash & Short-Term Investments | 4.3B |
| Receivables | 9.2B |
| Other Current Assets | 7.2B |
| Non-Current Assets | 6.3B |
| PP&E | 1.3B |
| Intangibles | 4.3B |
| Other Non-Current Assets | 672.6m |
| Current Liabilities | 8.5B |
| Accounts Payable | 4B |
| Accrued Liabilities | 160.6m |
| Short-Term Debt | 3B |
| Other Current Liabilities | 1.3B |
| Non-Current Liabilities | 1.3B |
| Long-Term Debt | 670.2m |
| Other Non-Current Liabilities | 663.4m |
Free Cash Flow Analysis
Entero Healthcare Solutions Ltd
| Free Cash Flow |
Earnings Waterfall
Entero Healthcare Solutions Ltd
|
Revenue
|
54B
|
|
Cost of Revenue
|
-48.8B
|
|
Gross Profit
|
5.3B
|
|
Operating Expenses
|
-3.7B
|
|
Operating Income
|
1.6B
|
|
Other Expenses
|
-559.5m
|
|
Net Income
|
1B
|
ENTERO Profitability Score
Profitability Due Diligence
Entero Healthcare Solutions Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Entero Healthcare Solutions Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
ENTERO Solvency Score
Solvency Due Diligence
Entero Healthcare Solutions Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
Entero Healthcare Solutions Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ENTERO Price Targets Summary
Entero Healthcare Solutions Ltd
According to Wall Street analysts, the average 1-year price target for ENTERO is 1 450.44 INR with a low forecast of 1 262.5 INR and a high forecast of 1 669.5 INR.
Dividends
Current shareholder yield for ENTERO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?